Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.

Liu LN, Wang G, Hendricks K, Lee K, Bohnlein E, Junker U, Mosca JD.

Stem Cells Transl Med. 2013 May;2(5):362-75. doi: 10.5966/sctm.2012-0135. Epub 2013 Apr 16.

2.

Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.

Merkel TJ, Perera PY, Kelly VK, Verma A, Llewellyn ZN, Waldmann TA, Mosca JD, Perera LP.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18091-6. doi: 10.1073/pnas.1013083107. Epub 2010 Oct 4.

3.

Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.

Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh S.

J Virol. 2007 Aug;81(16):8774-83. Epub 2007 Jun 6.

5.

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR.

J Biomed Sci. 2005;12(1):47-57.

PMID:
15864738
6.

Characterization and functionality of cell surface molecules on human mesenchymal stem cells.

Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, Mosca JD.

J Biomed Sci. 2003 Mar-Apr;10(2):228-41.

PMID:
12595759
7.

Human mesenchymal stem cells maintain transgene expression during expansion and differentiation.

Lee K, Majumdar MK, Buyaner D, Hendricks JK, Pittenger MF, Mosca JD.

Mol Ther. 2001 Jun;3(6):857-66.

8.

Orthopaedic gene therapy. Stem cells for gene delivery.

Caplan AI, Mosca JD.

Clin Orthop Relat Res. 2000 Oct;(379 Suppl):S98-100. No abstract available.

PMID:
11039757
9.

Mesenchymal stem cells as vehicles for gene delivery.

Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Böhnlein E, Storb R, Sandmaier BM.

Clin Orthop Relat Res. 2000 Oct;(379 Suppl):S71-90.

PMID:
11039755
10.

Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma.

Pittenger MF, Mosca JD, McIntosh KR.

Curr Top Microbiol Immunol. 2000;251:3-11. No abstract available.

PMID:
11036752
11.

Multilineage potential of adult human mesenchymal stem cells.

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR.

Science. 1999 Apr 2;284(5411):143-7.

12.

Mesenchymal stem cells in osteobiology and applied bone regeneration.

Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S.

Clin Orthop Relat Res. 1998 Oct;(355 Suppl):S247-56. Review.

PMID:
9917644
13.

Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.

Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL.

J Cell Physiol. 1998 Jul;176(1):57-66.

PMID:
9618145
14.

Monoclonal antibodies reactive with human osteogenic cell surface antigens.

Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE.

Bone. 1997 Sep;21(3):225-35.

PMID:
9276087
15.

Providing a Microenvironment for the Development of Human CD34+ Hematopoietic Cells in SCID Mice.

Kaushal S, La Russa VF, Hall ER, Gartner S, Kim JH, Perera LP, Yu Z, Kessler SW, Mosca JD.

J Biomed Sci. 1997 Mar-Jun;4(2-3):61-68.

PMID:
11725135
16.

Human mesenchymal stem cells respond to fibroblast growth factors.

van den Bos C, Mosca JD, Winkles J, Kerrigan L, Burgess WH, Marshak DR.

Hum Cell. 1997 Mar;10(1):45-50.

PMID:
9234064
17.

Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.

Kim JH, McLinden RJ, Mosca JD, Vahey MT, Greene WC, Redfield RR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):343-51.

PMID:
8673542
18.

Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.

Kim JH, McLinden RJ, Mosca JD, Burke DS, Boswell RN, Birx DL, Redfield RR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):329-42.

PMID:
8673541
19.

Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitro.

Kaushal S, La Russa VF, Gartner S, Kessler S, Perfetto S, Yu Z, Ritchey DW, Xu J, Perera P, Kim J, Reid T, Mayers DL, St Louis D, Mosca JD.

Blood. 1996 Jul 1;88(1):130-7.

20.

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.

Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, Wagner KF, Mayers DL, Burke DS, Weislow OS, St Louis DC, June CH.

Science. 1996 Jun 28;272(5270):1939-43.

PMID:
8658167
21.

Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Brown CR, Nakamura MS, Mosca JD, Hayward GS, Straus SE, Perera LP.

J Virol. 1995 Nov;69(11):7187-95.

22.

Characterization of a Human Stromal Cell Line Supporting Hematopoietic Progenitor Cell Proliferation: Effect of HIV Expression.

Mosca JD, Kaushal S, Gartner S, Kessler SW, La Russa VF, Terwilliger EF, Kim JH, Carroll RG, Hall ER, Perera LP, Yu Z, Ritchey DW, Xu J, St Louis DC, Mayers DL.

J Biomed Sci. 1995 Oct;2(4):330-342.

PMID:
11725070
23.

RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells.

Escaich S, Kalfoglou C, Plavec I, Kaushal S, Mosca JD, Böhnlein E.

Hum Gene Ther. 1995 May;6(5):625-34.

PMID:
7578399
25.

Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cells.

Kim JH, Ratto S, Sitz KV, Mosca JD, McLinden RJ, Tencer KL, Vahey MT, St Louis D, Birx DL, Redfield RR.

Hum Gene Ther. 1994 Dec;5(12):1457-66.

PMID:
7711138
26.

A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines.

Carroll R, Lin JT, Dacquel EJ, Mosca JD, Burke DS, St Louis DC.

J Virol. 1994 Sep;68(9):6047-51.

27.
28.

Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.

Michael NL, Vahey MT, d'Arcy L, Ehrenberg PK, Mosca JD, Rappaport J, Redfield RR.

J Virol. 1994 Feb;68(2):979-87.

29.

Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells.

Kim JH, Mosca JD, Vahey MT, McLinden RJ, Burke DS, Redfield RR.

AIDS Res Hum Retroviruses. 1993 Sep;9(9):875-82.

PMID:
7504936
30.

A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.

Perera LP, Mosca JD, Ruyechan WT, Hayward GS, Straus SE, Hay J.

J Virol. 1993 Aug;67(8):4474-83.

31.

The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter.

Perera LP, Mosca JD, Sadeghi-Zadeh M, Ruyechan WT, Hay J.

Virology. 1992 Nov;191(1):346-54.

PMID:
1329324
32.

Regulation of varicella-zoster virus gene expression in human T lymphocytes.

Perera LP, Mosca JD, Ruyechan WT, Hay J.

J Virol. 1992 Sep;66(9):5298-304. Erratum in: J Virol 1995 Apr;69(4):2723.

34.

Multi-step pathogenesis of AIDS--role of cytomegalovirus.

Fiala M, Mosca JD, Barry P, Luciw PA, Vinters HV.

Res Immunol. 1991 Feb;142(2):87-95. Review.

PMID:
1650955
36.

Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon.

Bednarik DP, Mosca JD, Raj NB, Pitha PM.

Proc Natl Acad Sci U S A. 1989 Jul;86(13):4958-62.

37.

Is there a role for herpesvirus in AIDS?

Mosca JD, Bednarik DP, Raj NB, Pitha PM.

Nature. 1988 Jan 14;331(6152):122. No abstract available.

PMID:
3340161
38.
39.

Methylation as a modulator of expression of human immunodeficiency virus.

Bednarik DP, Mosca JD, Raj NB.

J Virol. 1987 Apr;61(4):1253-7.

40.
41.

Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus.

Mosca JD, Bednarik DP, Raj NB, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM.

Nature. 1987 Jan 1-7;325(6099):67-70.

PMID:
3025748
44.

Increased 2',5'-oligoadenylate synthetase activity in blood mononuclear leukocytes from patients with advanced cutaneous T-cell lymphoma.

Vonderheid EC, Suhadolnik RJ, Sobel EL, Flick MB, Mosca JD.

Clin Immunol Immunopathol. 1984 Apr;31(1):138-50.

PMID:
6199147
45.

Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C.

Suhadolnik RJ, Sawada Y, Flick MB, Reichenbach NL, Mosca JD.

Cancer Res. 1983 Nov;43(11):5462-6.

46.

2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesis.

Suhadolnik RJ, Flick MB, Mosca JD, Sawada Y, Doetsch PW, Vonderheid EC.

Biochemistry. 1983 Aug 16;22(17):4153-8. No abstract available.

PMID:
6604547
47.
48.

Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.

Doetsch PW, Suhadolnik RJ, Sawada Y, Mosca JD, Flick MB, Reichenbach NL, Dang AQ, Wu JM, Charubala R, Pfleiderer W, Henderson EE.

Proc Natl Acad Sci U S A. 1981 Nov;78(11):6699-703.

49.

Enzymic synthesis of (2'-5')ppp3'dA(p3'dA)n, the cordycepin analog of (2'-5')-oligoadenylic acid.

Suhadolnik RJ, Doetsch P, Wu JM, Sawada Y, Mosca JD, Reichenbach NL.

Methods Enzymol. 1981;79(Pt B):257-65. No abstract available.

PMID:
6173670

Supplemental Content

Loading ...
Support Center